Patents by Inventor Conrad Stewart Winters

Conrad Stewart Winters has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS OF SPIRO-OXINDOLE COMPOUND FOR TOPICAL ADMINISTRATION AND THEIR USE AS THERAPEUTIC AGENTS
    Publication number: 20170095449
    Abstract: This invention is directed to pharmaceutical compositions for topical administration to a mammal, wherein the pharmaceutical compositions comprise a spiro-oxindole compound, as an enantiomer, a racemate or a non-racemic mixture, or a pharmaceutically acceptable salt thereof. These pharmaceutical compositions are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions.
    Type: Application
    Filed: October 11, 2016
    Publication date: April 6, 2017
    Inventors: Conrad Stewart Winters, Meidong Yang, Haigang Chen
  • Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
    Patent number: 9504671
    Abstract: This invention is directed to pharmaceutical compositions for topical administration to a mammal, wherein the pharmaceutical compositions comprise a spiro-oxindole compound, as an enantiomer, a racemate or a non-racemic mixture, or a pharmaceutically acceptable salt thereof. These pharmaceutical compositions are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions.
    Type: Grant
    Filed: February 25, 2011
    Date of Patent: November 29, 2016
    Assignee: Xenon Pharmaceuticals Inc.
    Inventors: Conrad Stewart Winters, Meidong Yang, Haigang Chen
  • PHARMACEUTICAL COMPOSITIONS OF SPIRO-OXINDOLE COMPOUND FOR TOPICAL ADMINISTRATION AND THEIR USE AS THERAPEUTIC AGENTS
    Publication number: 20130143941
    Abstract: This invention is directed to pharmaceutical compositions for topical administration to a mammal, wherein the pharmaceutical compositions comprise a spiro-oxindole compound, as an enantiomer, a racemate or a non-racemic mixture, or a pharmaceutically acceptable salt thereof. These pharmaceutical compositions are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions.
    Type: Application
    Filed: February 25, 2011
    Publication date: June 6, 2013
    Inventors: Conrad Stewart Winters, Meidong Yang, Haigang Chen
  • PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION
    Publication number: 20110086899
    Abstract: This invention is directed to pharmaceutical compositions for oral administration to a mammal, wherein the pharmaceutical compositions comprise a spiro-oxindole compound, as a single stereoisomer or as a mixture thereof, or a pharmaceutically acceptable salt thereof. These pharmaceutical compositions are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
    Type: Application
    Filed: October 14, 2010
    Publication date: April 14, 2011
    Applicant: XENON PHARMACEUTICALS INC.
    Inventors: Conrad Stewart Winters, Shaun Lee Gammill